BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 19116751)

  • 1. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
    Vather R; Sammour T; Kahokehr A; Connolly AB; Hill AG
    Ann Surg Oncol; 2009 Mar; 16(3):585-93. PubMed ID: 19116751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
    Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
    J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
    Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
    J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum.
    Tang R; Wang JY; Chen JS; Chang-Chien CR; Tang S; Lin SE; You YT; Hsu KC; Ho YS; Fan HA
    J Am Coll Surg; 1995 Jun; 180(6):705-12. PubMed ID: 7773484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer.
    Suzuki O; Sekishita Y; Shiono T; Ono K; Fujimori M; Kondo S
    J Am Coll Surg; 2006 May; 202(5):732-6. PubMed ID: 16648012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
    Rosenberg R; Friederichs J; Schuster T; Gertler R; Maak M; Becker K; Grebner A; Ulm K; Höfler H; Nekarda H; Siewert JR
    Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands.
    Kelder W; Inberg B; Schaapveld M; Karrenbeld A; Grond J; Wiggers T; Plukker JT
    Dis Colon Rectum; 2009 Feb; 52(2):260-7. PubMed ID: 19279421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
    Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
    Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer.
    Vather R; Sammour T; Kahokehr A; Connolly A; Hill A
    ANZ J Surg; 2011 Dec; 81(12):883-8. PubMed ID: 22507414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis.
    Gonsalves WI; Kanuri S; Tashi T; Aldoss I; Sama A; Al-Howaidi I; Ganta A; Kalaiah M; Thota R; Krishnamurthy J; Fang X; Townley P; Ganti AK; Subbiah S; Silberstein PT
    J Surg Oncol; 2011 Nov; 104(6):667-71. PubMed ID: 21337344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node evaluation of colon cancer and its association with improved staging and survival in the Department of Defense Health Care System.
    Lee S; Hofmann LJ; Davis KG; Waddell BE
    Ann Surg Oncol; 2009 Nov; 16(11):3080-6. PubMed ID: 19636635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.